May 6, 2014

Pinnacle Spine Group, LLC Announces CE Mark Approval for its Entire Line of InFill® Interbody Devices and its Patented Infill Graft Delivery System

Dallas, TX, May 6, 2014 – Pinnacle Spine Group has announced the CE (Conformité Européenne) Mark approval for its entire line of InFill Interbody Devices, as well as its patented InFill Graft Delivery System.

Pinnacle’s line of interbody devices includes the InFill Direct Lateral system, the InFill Lordotic Oblique TLIF, the InFill Convex Oblique TLIF, the InFill Contour Oblique TLIF, the InFill ALIF, and the InFill Cervical Lordotic, and InFill Anatomic interbody devices.

Pinnacle also received CE Mark approval for its novel InFill Graft Delivery System, which initial studies have shown can place up to 94% more biologic between the vertebral bodies using the lateral approach than traditional prepacking of the implant

“We are very pleased that we are now able to expand our operations into the European market. We believe that our novel approach to fusion, which includes the ability to deliver graft directly into the disc space, will resonate as well with the European spinal community as it has here in the USA. We look forward to developing a strong presence in CE Mark countries within Europe,” says Zach Sowell, Vice President of Marketing for Pinnacle Spine.

About Pinnacle Spine Group, LLC

Pinnacle Spine Group is committed to developing spinal fusion systems that improve the results for the patient, surgeon and hospital. Based around the concept of delivering a more complete fill of the disc space with graft material, the company believes it can enhance outcomes for all parties.